NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email The Tar Heels’ second straight first-round NCAA Tournament exit adds to growing questions about the program’s directionRead More
NBA Panic Meter Power Rankings: Which teams should be most concerned about the first roundApril 27, 2026